UPDATE : Wednesday, August 12, 2020
Experts caution against hasty use of Olumiant for new coronavirus by Kim Yun-mi 2020-02-06 16:08
MSD to spin off women’s health, biosimilars under new firm by Kim Yun-mi 2020-02-06 13:07
Helixmith presents study results of neuropathic pain treatment by Shim Hyun-tai 2020-02-05 18:43
‘Baricitinib emerges as potential treatment for new coronavirus’ by Lee Han-soo 2020-02-05 16:32
Medytox, Daewoong in final battle over BTX strain ownership by Jeong Sae-im 2020-02-05 12:41
Interferon, Kaletra to get insurance benefit for new coronavirus treatment by Kim Yun-mi 2020-02-04 16:39
‘Gilead’s drug candidate effective to fight new coronavirus’ by Kim Yun-mi 2020-02-04 16:39
Boryung Holdings sets up US offshoot by Lee Han-soo 2020-02-03 16:28
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads by Jeong Sae-im 2020-02-03 15:21
New coronavirus affect related stocks in different ways by Jeong Sae-im 2020-01-30 17:36
Celltrion tops list of pharmaceutical brand reputation in January by Jeong Sae-im 2020-01-30 16:10
Merck Korea worker commits suicide by Kim Yun-mi 2020-01-30 16:09
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod by Kim Yun-mi 2020-01-30 14:07
Hanmi targets revenue of ₩100 billion from Rosuzet sales by Shim Hyun-tai 2020-01-29 18:05
Drugmaker cancels event for 1,000 doctors due to new coronavirus risk by Park Gi-taek 2020-01-29 15:51
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’ by Kim Yun-mi 2020-01-29 14:00
Afstyla wins nod as new therapy for hemophilia A by Kim Yun-mi 2020-01-24 08:18
MIT promotes industrial liaison program to Korean drugmakers by Jeong Sae-im 2020-01-23 12:04
'Reimbursement for Repatha to expand treatment options for ASCVD patients' by Lee Han-soo 2020-01-22 15:14
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019 by Kim Yun-mi 2020-01-22 15:10
Back to Top